Canonical Wnt/Β-catenin signaling mediates transforming growth factor-Β1-driven podocyte injury and proteinuria

Kidney International

Volumn 80, Issue 11, 2011, Pages 1159-1169

  Wang, Dan ^a   Dai, Chunsun ^a,b   Li, Yingjian ^a   Liu, Youhua ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALVASCULIN; DESMIN; DICKKOPF 1 PROTEIN; GELATINASE B; MATRILYSIN; NEPHRIN; PROTEIN INHIBITOR; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1; WNT PROTEIN;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL FUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVATION; ENZYME REPRESSION; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SECRETION; PROTEIN TARGETING; PROTEINURIA; RENAL PROTECTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 81155150123     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.255     Document Type: Article

References (49)

1. Patrakka J, Tryggvason K. New insights into the role of podocytes in proteinuria. Nat Rev Nephrol 2009; 5: 463-468.
2. Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007; 71: 1205-1214. (Pubitemid 46884251)
3. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006; 69: 2131-2147. (Pubitemid 43882099)
4. Schnaper HW, Jandeska S, Runyan CE et al. TGF-beta signal transduction in chronic kidney disease. Front Biosci 2009; 14: 2448-2465.
5. Bottinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol 2002; 13: 2600-2610.
6. Li Y, Kang YS, Dai C et al. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 2008; 172: 299-308. (Pubitemid 351282018)
7. Wu DT, Bitzer M, Ju W et al. TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes. J Am Soc Nephrol 2005; 16: 3211-3221. (Pubitemid 46179327)
8. Kopp JB, Factor VM, Mozes M et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 1996; 74: 991-1003. (Pubitemid 26182412)
9. Schiffer M, Bitzer M, Roberts IS et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001; 108: 807-816. (Pubitemid 32880291)
10. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006; 127: 469-480.
11. Angers S, Moon RT. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 2009; 10: 468-477.
12. Schmidt-Ott KM, Barasch J. WNT/beta-catenin signaling in nephron progenitors and their epithelial progeny. Kidney Int 2008; 74: 1004-1008.
13. Carroll TJ, Park JS, Hayashi S et al. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell 2005; 9: 283-292. (Pubitemid 41051746)
14. He W, Dai C, Li Y et al. Wnt/b-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 2009; 20: 765-776.
15. Dai C, Stolz DB, Kiss LP et al. Wnt/b-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 2009; 20: 1997-2008.
16. von Toerne C, Schmidt C, Adams J et al. Wnt pathway regulation in chronic renal allograft damage. Am J Transplant 2009; 9: 2223-2239.
17. Surendran K, Schiavi S, Hruska KA. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol 2005; 16: 2373-2384. (Pubitemid 41725055)
18. Heikkila E, Juhila J, Lassila M et al. b-Catenin mediates adriamycin-induced albuminuria and podocyte injury in the adult mouse kidneys. Nephrol Dial Transplant 2010; 25: 2437-2446.
19. He W, Kang YS, Dai C et al. Blockade of Wnt/b-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol 2011; 22: 90-103.
20. Semenov MV, Tamai K, Brott BK et al. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 2001; 11: 951-961. (Pubitemid 32589186)
21. Dai C, Yang J, Liu Y. Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol 2002; 13: 411-422. (Pubitemid 34106284)
22. Yang J, Chen S, Huang L et al. Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology 2001; 33: 848-859. (Pubitemid 32246634)
23. Dai C, Yang J, Bastacky S et al. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J Am Soc Nephrol 2004; 15: 2637-2647. (Pubitemid 41103370)
24. Brunner AM, Marquardt H, Malacko AR et al. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor. Expression and characterization of mutant proteins. J Biol Chem 1989; 264: 13660-13664. (Pubitemid 19198449)
25. He W, Tan R, Dai C et al. Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/b-catenin signaling. J Biol Chem 2010; 285: 24665-24675.
26. Hirota M, Watanabe K, Hamada S et al. Smad2 functions as a co-activator of canonical Wnt/beta-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300. Cell Signal 2008; 20: 1632-1641.
27. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010; 21: 212-222.
28. Thiery JP, Acloque H, Huang RY et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
29. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
30. Yamaguchi Y, Iwano M, Toyoda M et al. Epithelial-mesenchymal transition as an explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis 2009; 54: 653-664.
31. Boutet A, De Frutos CA, Maxwell PH et al. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 2006; 25: 5603-5613. (Pubitemid 44847200)
32. Cano A, Perez-Moreno MA, Rodrigo I et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 76-83.
33. Vincent T, Neve EP, Johnson JR et al. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol 2009; 11: 943-950.
34. ten Berge D, Koole W, Fuerer C et al. Wnt signaling mediates self-organization and axis formation in embryoid bodies. Cell Stem Cell 2008; 3: 508-518.
35. Matsui I, Ito T, Kurihara H et al. Snail, a transcriptional regulator, represses nephrin expression in glomerular epithelial cells of nephrotic rats. Lab Invest 2007; 87: 273-283. (Pubitemid 46353945)
36. Chang H, Gao F, Guillou F et al. Wt1 negatively regulates beta-catenin signaling during testis development. Development 2008; 135: 1875-1885.
37. Kim MS, Yoon SK, Bollig F et al. A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway. J Biol Chem 2010; 285: 14585-14593.
38. Hovanes K, Li TW, Munguia JE et al. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 2001; 28: 53-57. (Pubitemid 32405817)
39. Brabletz T, Jung A, Dag S et al. beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 1999; 155: 1033-1038. (Pubitemid 29488909)
40. Gerke P, Sellin L, Kretz O et al. NEPH2 is located at the glomerular slit diaphragm, interacts with nephrin and is cleaved from podocytes by metalloproteinases. J Am Soc Nephrol 2005; 16: 1693-1702. (Pubitemid 41716475)
41. Eddy AA, Fogo AB. Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol 2006; 17: 2999-3012. (Pubitemid 44707760)
42. Stein U, Arlt F, Walther W et al. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Gastroenterology 2006; 131: 1486-1500. (Pubitemid 44708942)
43. Okada H, Danoff TM, Kalluri R et al. Early role of Fsp1 in epithelialmesenchymal transformation. Am J Physiol 1997; 273: F563-F574.
44. Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 2006; 25: 7469-7481. (Pubitemid 44885746)
45. Takano Y, Yamauchi K, Hiramatsu N et al. Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrin. Am J Physiol Renal Physiol 2007; 292: F1573-F1582. (Pubitemid 46701885)
46. Liu Y, Tolbert EM, Sun AM et al. Primary structure of rat HGF receptor and induced expression in glomerular mesangial cells. Am J Physiol 1996; 271: F679-F688.
47. Dai C, Saleem MA, Holzman LB et al. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria. Kidney Int 2010; 77: 962-973.
48. Li Y, Tan X, Dai C et al. Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. J Am Soc Nephrol 2009; 20: 1907-1918.
49. Wang D, Li Y, Wu C et al. PINCH1 is transcriptional regulator in podocytes that interacts with WT1 and represses podocalyxin expression. PLoS ONE 2011; 6: e17048.